Standout Papers

Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 c... 2007 2026 2013 2019 780
  1. Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial (2007)
    Lu Zhang, Ferenc Martényi et al. Nature Medicine

Immediate Impact

4 by Nobel laureates 20 from Science/Nature 60 standout
Sub-graph 1 of 20

Citing Papers

Psychotropic Drug–Related Weight Gain and Its Treatment
2024 Standout
Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors
2023 StandoutScience
2 intermediate papers

Works of Sergey Mosolov being referenced

Efficacy of valproate versus lithium in mania or mixed mania: a randomized, open 12-week trial
2010
Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial
2007 Standout

Author Peers

Author Last Decade Papers Cites
Sergey Mosolov 1017 390 322 606 434 104 1.9k
Andreas Erfurth 1089 406 358 541 290 120 2.4k
Nobuhisa Kanahara 874 342 198 556 411 92 1.9k
Hanns Hippius 1152 266 387 402 384 128 2.6k
Belén Arranz 819 238 258 559 326 99 1.8k
Richard L. Borison 1056 325 374 539 307 66 1.9k
A.J.M. Loonen 879 227 248 570 362 159 2.3k
E. Zarifian 728 168 375 779 493 83 2.0k
Dorotea Mück‐Šeler 761 452 433 766 459 99 2.6k
Stephen Cooper 1382 471 365 505 260 83 2.7k
G. William MacEwan 1400 482 357 507 218 82 2.6k

All Works

Loading papers...

Rankless by CCL
2026